Navigation Links
Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
Date:7/3/2012

PITTSBURGH, July 3, 2012 /PRNewswire/ -- There is no question that being a parent is, at times, challenging both physically and mentally. However knowledge of the actual affect parenthood has on health has been inconsistent at best, until now.

(Logo: http://photos.prnewswire.com/prnh/20020422/CMULOGO )

New research led by Carnegie Mellon University's Sheldon Cohen and Rodlescia S. Sneed shows that being a parent influences health in a positive way. Published in Psychosomatic Medicine, the research provides the first evidence that, when exposed to a common cold virus, parents are 52 percent less likely to develop a cold than non-parents.

"We have had a long-term interest in how various social relationships influence health outcomes," said Cohen, the Robert E. Doherty Professor of Psychology within CMU's Dietrich College of Humanities and Social Sciences. "Parenthood was especially interesting to us because it has been proposed that it can have both positive and negative effects on health. For example, being a parent can be stressful but at the same time can be fulfilling, facilitate the development of a social network and provide purpose in life."

For the study, Cohen, Sneed, Ronald B. Turner of the University of Virginia Health Center and William J. Doyle of the University of Pittsburgh School of Medicine exposed 795 healthy adults between the ages of 18 and 55 to a virus that causes a common cold. Participants reported their parenthood status, and analyses were controlled for immunity to the experimental virus, viral strain, season, age, sex, race, ethnicity, marital status, body mass, employment status and education.

Parents with one or two children were 48 percent less likely to get sick while parents with three or more children were 61 percent less likely to develop a cold. Both parents with children living at home and away from home showed a decreased risk of catching a cold. And, while parents older than age 24 were protected from the cold virus, parenthood did not influence whether those aged 18-24 became ill.

"Although parenthood was clearly protective, we were unable to identify an explanation for this association," Cohen said.  "Because we controlled for immunity to the virus, we know that these differences did not occur just because the parents were more likely to have been exposed to the virus through their children.  Moreover, parents and nonparents showed few psychological or biological differences, and those that did exist could not explain the benefit of parenthood.  We expect that a psychological benefit of parenthood that we did not measure may have been responsible."

This research was funded by the National Center for Complementary and Alternative Medicine, the National Institute of Mental Health, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, the John D. and Catherine T. MacArthur Foundation Network on Socioeconomic Status and Health, and a grant from the National Institutes of Health to the University of Pittsburgh Medical Center General Clinical Research Center.

About Carnegie Mellon University: Carnegie Mellon (www.cmu.edu) is a private, internationally ranked research university with programs in areas ranging from science, technology and business, to public policy, the humanities and the arts. More than 11,000 students in the university's seven schools and colleges benefit from a small student-to-faculty ratio and an education characterized by its focus on creating and implementing solutions for real problems, interdisciplinary collaboration and innovation. A global university, Carnegie Mellon's main campus in the United States is in Pittsburgh, Pa. It has campuses in California's Silicon Valley and Qatar, and programs in Asia, Australia, Europe and Mexico. The university is in the midst of "Inspire Innovation: The Campaign for Carnegie Mellon University," which aims to build its endowment, support faculty, students and innovative research, and enhance the physical campus with equipment and facility improvements.


'/>"/>
SOURCE Carnegie Mellon University
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Midwest Prepares to Tackle Gnats with an Unlikely Weapon
2. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
3. ASCO Impact Report From Encuity Research Indicates Oncologists Are Likely to Shift Patient Treatment Plans
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
6. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
8. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
9. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
10. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
11. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology:
(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):